Improving outcomes in the management of Gram-negative bacterial infections in the face of growing antimicrobial resistance.
26th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2016): 9-12 April 2016, Amsterdam, The Netherlands The European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), the annual meeting of the European Society of Clinical Microbiology, had a record attendance at the 2016 meeting, with more than 11,600 scientists and clinicians from 120 countries sharing the latest research and information on infectious diseases. This article reviews sessions on the growing threat of antibiotic resistance in the management of Gram-negative bacterial infections and potential solutions, including optimizing initial drug choice and dosing, development of new options and improving antimicrobial stewardship.
Susan Mayor Limited Communications, London, UK.
Susan
S
Mayor
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D015780:Carbapenems; D003226:Congresses as Topic; D004338:Drug Combinations; D024881:Drug Resistance, Bacterial / Q000187:drug effects*; D006090:Gram-Negative Bacteria / Q000187:drug effects* / Q000472:pathogenicity*; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D007709:Klebsiella / Q000187:drug effects; D009426:Netherlands; D011159:Population Surveillance; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D012307:Risk Factors; D016896:Treatment Outcome; D001618:beta-Lactamases
D000900:Anti-Bacterial Agents; D015780:Carbapenems; D004338:Drug Combinations; D001618:beta-Lactamases
ESBL; Gram-negative; antibiotics; bacteria; extended-spectrum β-lactamase; infections; resistance